智通财经APP获悉，启明医疗-B(02500)盘中涨超7%，截至发稿，涨4.05%，报2.57港元，成交额489.42万港元。
消息面上，启明医疗近期宣布，Cardiovalve经导管三尖瓣置换系统已正式向欧洲公告机构递交CE认证的全部申请资料，标志着该产品在欧洲市场的准入进程迈出关键一步。
截至目前，Cardiovalve系统已在欧洲顺利完成确证性临床研究全部150例患者入组，并于今年的伦敦心脏瓣膜介入治疗会议上正式发布TARGET研究的中期结果，数据表现积极，受到海外研究者专家团队的认可与好评。此次Cardiovalve系统正式步入CE认证阶段，意味着启明医疗在“四瓣一体”的产品战略布局上更进一步，在已成熟的主瓣、肺瓣产品线基础上，进一步完善了三尖瓣治疗矩阵。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.